![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
FDF China to be held in June to boost Chinese pharmaceutical enterprises to “go...
FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai...
Discover the Latest Information and Seize Market Opportunities in the Annual Event of the...
As the pharmaceutical market demands in China continue to grow, China’s pharmaceutical policies become gradually...
IONTAS and Adaptate Biotherapeutics collaborate to identify optimised antibodies for novel cancer targets
IONTAS, a leader in the discovery and optimisation of fully human antibodies, announced it has...
BioMotiv and Atomwise Sign AI Partnership to Transform Therapeutic Development
BioMotiv, a mission-driven pharma company part of The Harrington Project for discovery and development, and...
Astellas Announces Construction of New Manufacturing Facility for Active Pharmaceutical Ingredient of Prograf
The new manufacturing facility is designed to have advanced features based on the efficiency of...
CytoviaTherapeutics and the University of California enter into a partnership to develop precision gene-edited...
CytoviaTherapeutics,a biopharmaceutical company, and the University of California,San Francisco(UCSF) announced that they have entered a...
Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of...
Boehringer Ingelheim and Enleofen Bio Pte. Ltd. (Enleofen) announced the acquisition of worldwide exclusive rights...
BI Vaccines Announces Second Pivotal Phase 3 Study of Sci-B-Vac Meets Primary and Secondary...
VBI Vaccines Inc. (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines,...
Generation Bio Announces $110 Million Series C Financing to Advance Lead Programs for Hemophilia...
Generation Bio, a company leading a new generation of gene therapy, announced the closing of...
Bayer and Exscientia collaborate to leverage the potential of AI in cardiovascular and oncology...
Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into...